Skip to content
Screener

Cytek Biosciences, Inc. CTKB APAC — Total revenue, net

Other geography segments

EMEA
$11.3M-8.2%
Other
$701K-54.2%

Similar metrics at other companies

Rubrik logo
RBRKAPAC — Total Revenue
$15.97M+45.7%
Fortinet logo
FTNTAPAC — Total Revenue
$325M+15.5%
3D Systems logo
DDDAPAC — Total Revenue
$4.13M-54.9%
Everspin Technologies logo
MRAMAPAC — Total Revenue
$10.87M+26.6%
Adobe logo
ADBEAPAC — Total Revenue
$840M+9.8%
Guidewire Software logo
GWRETotal APAC — Total Revenue
$32.46M+27.9%

Other financials

Income statement

See full
Revenue$48.1M+5.6%
Gross profit$28.3M+18.7%
Operating income-$11.4M-7.3%
Net income-$12.2M-118%
EPS (diluted)-$0.09-125%

Balance sheet

See full
Cash & equivalents$73.8M-2.2%
Total debt$17.0M-6.6%
Total equity$322.0M-14.7%
Total assets$446.9M-9.4%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+40.5%
Free cash flow-$849.0K+42.2%

Valuation

See full
Market cap$545.93M+25.6%
Enterprise value$489.11M+29.2%
P/S2.6×+0.4×

Profitability

See full
Gross margin53.2%-1.2pp
Operating margin-21.6%
Net margin-39%
FCF margin-5.8%-11.4pp

Returns & leverage

See full
Return on equity-23%
Debt / equity0.1×0.0×
Current ratio4.5×-0.7×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053496
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
United States$28,220$23,894$52,607$42,429
EMEA11,30412,30922,06923,875
APAC7,9157,86715,66616,758
Other7011,5321,9333,997
Total revenue, net$48,140$45,602$92,275$87,059

Item 1. Consolidated Financial Statements (Unaudited)

FAQ

What is Cytek Biosciences, Inc.'s APAC — total revenue, net?
Cytek Biosciences, Inc. (CTKB) reported APAC — total revenue, net of $7.92M in Q2 2026.
How has Cytek Biosciences, Inc.'s APAC — total revenue, net changed year-over-year?
Cytek Biosciences, Inc.'s APAC — total revenue, net increased by 0.6% year-over-year, from $7.87M to $7.92M.
What is the long-term trend for Cytek Biosciences, Inc.'s APAC — total revenue, net?
Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s APAC — total revenue, net has grown at a 26.4% compound annual growth rate (CAGR), from $16.08M to $41.08M.
What does APAC — total revenue, net mean?
This metric represents the total net revenue generated from the Asia-Pacific geographic region, reflecting the company's market penetration and commercial success in these specific international markets. It serves as a key indicator of the company's ability to scale its global footprint and capture demand for its specialized technology within this territory.

Ask your AI about Cytek Biosciences, Inc.'s apac — total revenue, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude